In ischemic contexts, IL-17 creates a proarrhythmic setting by impairing electrical conduction, prolonging repolarization, and promoting both myocardial fibrosis and inflammation—effects that are reversible with IL-17 neutralization [39]. This evidence concerns the gene IL17A and Myocardial fibrosis.